When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully
Kent Rogers, Acorda Therapeutics
Advertisement
Articles by Kent Rogers, Acorda Therapeutics
Advertisement
Latest Updated Articles
- What manufacturers should anticipate when working with specialty pharmacies
Published: February 27th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
CEVA Logistics Expands End-to-End Capabilities With Acquisition of Project Logistics Specialist Fagioli
2
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
3
Trade & Channel Strategies 2025: Why Product-Level Strategy Matters More Than Ever
4
Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s
5